FDA
-
-
-
-
-
-
-
InMed Provides Business Update and Milestones for 2023
-
-
-
-
-
-
-
InMed Pharmaceuticals Inc. (INM) Reports Q2, Provides Business Update
-
-
-
-
-
-
-
InMed Pharmaceuticals Inc. (INM) Reports Submission of Clinical Trial Applications to Evaluate INM-755 (Cannabinol) Cream in a Phase 2 Trial for Epidermolysis Bullosa
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

